1. Repository of OAI
Ελληνικά   English  

Browsing by Author Skarlos, D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 16 to 35 of 66 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group StudyNicolaides, C.; Fountzilas, G.; Zoumbos, N.; Skarlos, D.; Kosmidis, P.; Pectasides, D.; Karabelis, A.; Giannakakis, T.; Symeonidis, A.; Papadopoulos, A.; Antoniou, F.; Pavlidis, N.24-Nov-2015-
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility studyFountzilas, G.; Nicolaides, C.; Aravantinos, G.; Skarlos, D.; Kosmidis, P.; Papakostas, P.; Stathopoulos, G. P.; Kontostolis, E.; Bafaloukos, D.; Pavlidis, N.24-Nov-2015-
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancerFountzilas, G.; Papadimitriou, C.; Aravantinos, G.; Nicolaides, C.; Stathopoulos, G.; Bafaloukos, D.; Kalofonos, H.; Ekonomopoulos, T.; Skarlos, D.; Pavlidis, N.; Dimopoulos, A. M.24-Nov-2015-
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Papadimitriou, C.; Dafni, U.; Bafaloukos, D.; Skarlos, D.; Moulopoulos, L. A.; Razis, E.; Kalofonos, H. P.; Aravantinos, G.; Briassoulis, E.; Papakostas, P.; Abela, K.; Gogas, E.; Kosmidis, P.; Pavlidis, N.; Dimopoulos, M. A.24-Nov-2015-
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experiencePectasides, D.; Fountzilas, G.; Aravantinos, G.; Bamias, A.; Kalofonos, H. P.; Skarlos, D.; Briasoulis, E.; Konstantara, A.; Economopoulos, T.; Dimopoulos, M. A.24-Nov-2015-
Evaluation of 6 Tumor-Markers in Patients with Carcinoma of Unknown PrimaryPavlidis, N.; Kalefezra, J.; Briassoulis, E.; Skarlos, D.; Kosmidis, P.; Saferiadis, K.; Bairaktari, E.; Bafaloukos, D.; Maravegias, A.; Theoharis, D.; Fountzilas, G.24-Nov-2015-
Evaluation of six tumor markers in patients with carcinoma of unknown primaryPavlidis, N.; Kalef-Ezra, J.; Briassoulis, E.; Skarlos, D.; Kosmidis, P.; Saferiadis, K.; Bairaktari, E.; Bafaloukos, D.; Maravegias, A.; Theoharis, D.; et al.,24-Nov-2015-
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyKostopoulos, I.; Arapantoni-Dadioti, P.; Gogas, H.; Papadopoulos, S.; Malamou-Mitsi, V.; Scopa, C. D.; Markaki, S.; Karagianni, E.; Kyriakou, V.; Margariti, A.; Kyrkou, E.; Pavlakis, K.; Zaramboukas, T.; Skordalaki, A.; Bourli, A.; Markopoulos, C.; Pectasides, D.; Dimopoulos, M. A.; Skarlos, D.; Fountzilas, G.24-Nov-2015-
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II studyPectasides, D.; Dimopoulos, M. A.; Aravantinos, G.; Kalophonos, H. P.; Papacostas, P.; Briasoulis, E.; Cogas, E.; Papadimitriou, C.; Skarlos, D.; Kosmidis, P.; Fountzilas, G.24-Nov-2015-
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Dimopoulos, A. M.; Papadimitriou, C.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Athanassiades, A.; Nicolaides, C.; Keramopoulos, A.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Zisiadis, A.; Dafni, U.; Konstantaras, C.; Hatzitheoharis, G.; Papavramidis, S.; Bousoulegas, A.; Basdanis, G.; Giannoulis, E.; Dokmetzioglou, J.; Katsohis, C.; Nenopoulou, E.; Karvounis, N.; Briassoulis, E.; Aravantinos, G.; Kosmidis, P.; Skarlos, D.; Pavlidis, N.24-Nov-2015-
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology GroupKosmidis, P. A.; Tsavaris, N.; Skarlos, D.; Theocharis, D.; Samantas, E.; Pavlidis, N.; Briassoulis, E.; Fountzilas, G.24-Nov-2015-
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialPentheroudakis, G.; Kalogeras, K. T.; Wirtz, R. M.; Grimani, I.; Zografos, G.; Gogas, H.; Stropp, U.; Pectasides, D.; Skarlos, D.; Hennig, G.; Samantas, E.; Bafaloukos, D.; Papakostas, P.; Kalofonos, H. P.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group studyFountzilas, G.; Skarlos, D.; Katsohis, C.; Pavlidis, N.; Giannakakis, T.; Bafaloukos, D.; Fahantidis, E.; Klouvas, G.; Beer, M.; Kosmidis, P.24-Nov-2015-
High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group studyFountzilas, G.; Skarlos, D.; Pavlidis, N. A.; Makrantonakis, P.; Tsavaris, N.; Kalogera-Fountzila, A.; Giannakakis, T.; Beer, M.; Kosmidis, P.24-Nov-2015-
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG)Nicolaides, C.; Klouvas, G.; Fountzilas, G.; Athanassiadis, A.; Skarlos, D.; Samantas, E.; Kosmidis, P.; Mylonakis, N.; Pavlidis, N.24-Nov-2015-
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancerFountzilas, G.; Skarlos, D.; Giannakakis, T.; Athanasiadis, A.; Bafaloukos, D.; Kalogera-Fountzila, A.; Bamia, C.; Pavlidis, N.; Kosmidis, P.24-Nov-2015-
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 womenPentheroudakis, G.; Fountzilas, G.; Bafaloukos, D.; Koutsoukou, V.; Pectasides, D.; Skarlos, D.; Samantas, E.; Kalofonos, H. P.; Gogas, H.; Pavlidis, N.24-Nov-2015-
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group studyBriasoulis, E.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Xiros, N.; Aravantinos, G.; Samantas, E.; Kalofonos, H.; Makatsoris, T.; Mylonakis, N.; Papakostas, P.; Skarlos, D.; Varthalitis, I.; Pavlidis, N.24-Nov-2015-
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)Kosmidis, P.; Mylonakis, N.; Skarlos, D.; Samantas, E.; Dimopoulos, M.; Papadimitriou, C.; Kalophonos, C.; Pavlidis, N.; Nikolaidis, C.; Papaconstantinou, C.; Fountzilas, G.24-Nov-2015-
Showing results 16 to 35 of 66 < previous   next >